This Falling Scalpel Could Cut You

In this video, health-care analysts David Williamson and Max Macaluso discuss the recent 20% plunge suffered by Edwards Lifesciences investors and whether the factors behind the substantial revenue miss make the stock a bad news buy or if investors will be cut trying to catch a falling knife.

We all would like to build long-term wealth and retire well, but buying stocks after a sudden plunge isn't a surefire strategy. In our free report "3 Stocks That Will Help You Retire Rich," we reveal some stocks that could help you as well as some winning wealth-building strategies. Click here to keep reading.

The article This Falling Scalpel Could Cut You originally appeared on Fool.com.

Dave Williamson and Max Macaluso have no positions in the stocks mentioned above. The Motley Fool owns shares of Dendreon and St. Jude Medical. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.